Intravenous Laser Blood Irradiation and Tocilizumab in a Patient with Juvenile Arthritis
This study presents effects of intravenous laser blood irradiation (ILBI) in a transient immunodeficiency patient with juvenile idiopathic arthritis (JIA) treated with an interleukin-6 receptor inhibitor (Tocilizumab).Biological agents induce JIA remission, but some patients do not respond favorably to this final therapeutic line of defense.ILBI wa